COVID-19 Urgency for a Vaccine Demands Patience

Drug Pricing Lab
May 16, 2020

Amidst today’s unprecedented global pandemic, developing diagnostics and treatments for COVID-19 is paramount. Yet the urgency for development has popularized a false dichotomy that risk taking that involves forgoing traditional regulatory protocol leads to an expedited timeline for developing effective treatments. Published in the New York Times, Dr. Peter Bach and Dr. Kent Sepkowitz write, “Urgency demands patience, because advancement is always a product of missteps.” The mission to develop a COVID-19 vaccine is well served if we heed the natural scientific guardrails of the development process, and Dr. Bach speaks to this in The New Yorker.

Read full interview here.